Black Diamond Therapeutics, Inc. (BDTX): SCHEDULE 13G/A filed Mar 21, 2025

Name: Black Diamond Therapeutics, Inc. SCHEDULE 13G/A (0001104659-25-026516)
Creator: Black Diamond Therapeutics, Inc.
Published: 2025-03-21

Form type: SCHEDULE 13G/A
Filing date: Mar 21, 2025
Accession number: 0001104659-25-026516
Filer: Black Diamond Therapeutics, Inc. (CIK 1701541)